Somatostatinoma: Clinical Trials

3 trials for Somatostatinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Somatostatinoma: new trials by email Literature Review of Somatostatinoma trials Research Report on Somatostatinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Indium-111 pentetreotide - Neuroendocrine Tumors
Phase 2 / Phase 3CompletedRadio Isotope Therapy of America2002005-08-012023-04-03
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
bevacizumab, 5-fluorouracil, leucovorin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor
Phase 2 / Phase 3TerminatedUniversity of California, San Francisco362005-06-082023-05-22

Narrower conditions

Carcinoma, Islet Cell (2)  ·  Gastrinoma (2)  ·  Glucagonoma (2)  ·  Insulinoma (2)  ·  Neoplasms (2)  ·  Neuroendocrine Tumors (2)  ·  Vipoma (2)  ·  Adenoma, Islet Cell (1)  ·  Adrenocortical Carcinoma (1)  ·  Anus Neoplasms (1)  ·  Appendiceal Neoplasms (1)  ·  Astrocytoma (1)  ·  Bile Duct Neoplasms (1)  ·  Blast Crisis (1)

Broader conditions

Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Carcinoma, Neuroendocrine (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)  ·  Pancreatic Diseases (3)  ·  Adenoma (2)

Interventions

Bevacizumab (1)  ·  Fentanyl (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)

Sponsors

INSYS Therapeutics Inc (1)  ·  Radio Isotope Therapy of America (1)  ·  University of California, San Francisco (1)

Countries

United States (3)

Top investigators

Ebrahim Delpassand, M.D. (1)  ·  Emily K. Bergsland, MD (1)  ·  Larry Dillaha, MD (1)

Results publications

PMID 22480131, PMID 27020837